InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank86
3Y CAGR-8.5%
5Y CAGR+3.2%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-8.5%/yr
Annual compound
5Y CAGR
+3.2%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.05-41.6%
20240.08+193.2%
20230.03-55.3%
20220.06+125.1%
20210.03-32.1%
20200.04-
20190.00-
20180.00-
20170.00-
20160.00-